Health News Archive - January 12, 2009
CAMBRIDGE, England, January 12 /PRNewswire/ -- Biotica Technology Limited, a privately-held biotechnology company, announces a significant Collaboration and License Agreement with GlaxoSmithKline to discover, develop and commercialise novel erythromycin-based macrolides in inflammatory diseases. In a three year research collaboration, Biotica will use its bioengineering technology to produce compounds that are not readily accessible via conventional medicinal chemistry approaches.
MADISON, Wis., Jan. 12 /PRNewswire/ -- Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease (AD), announced today that it held an initial closing of $2.9 million in Series B Preferred Stock financing.
JERUSALEM, Jan. 12 /PRNewswire/ -- Chiasma, Inc. today made the following announcements: Using the Company's proprietary Transient Permeability Enhancer (TPE) technology, scientists at Chiasma have delivered drugs orally in animal models that previously had only been available via injection.
STOCKHOLM, January 12 /PRNewswire/ -- Sweden The Swedish investment company Karolinska Development AB has made a significant investment in EvoStem Finland Oy that develops stem cell and other tissue engineering based treatments for veterinary and human use. In 2007 EvoStem Finland Oy introduced its first product TendoStem(R), which is a stem cell based treatment service for tendon and ligament injuries in horses.
ST HELIER, Jersey, January 12 /PRNewswire/ -- - Reflects Strong International Growth and Successful Diversification of World's Leading IP Management Specialist and Legal Support Services Firm CPA Global, the world's top intellectual property (http://www.cpaglobal.com) (IP) management specialist and a leading provider of outsourced legal support services, has today marked its 40th anniversary year with the launch of a new brand worldwide. Founded in 1969 as a specialist IP firm in Jersey, Channel Islands, CPA Global is today a global organisation of more than 1,200 people, providing a wide range of IP and legal support services to clients in over 100 countries. Formally known as CPA (from its original name of Computer Patent Annuities (http://www.cpaglobal.com/patents)), the group has grown over the years through a combination of acquisition and organic growth.
SAN FRANCISCO, Jan.
CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Ted Hibben has joined the company as chief business officer. Mr.
NORWALK, Conn., Jan.
CAMBRIDGE, Mass., Jan. 12 /PRNewswire/ -- Solace Pharmaceuticals, a private biotechnology company discovering and developing innovative treatments for pain, announced the initiation of a proof-of-concept clinical trial of SLC022 in patients with post-herpetic neuralgia (PHN).
HAYWARD, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM) announced that effective today it has changed its corporate name to Solta Medical, Inc. At the open of the NASDAQ exchange this morning, Solta Medical, Inc.